These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12005246)

  • 41. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.
    el-Agroudy AE; Hassan NA; Foda MA; Ismail AM; el-Sawy EA; Mousa O; Ghoneim MA
    Am J Nephrol; 2003; 23(5):300-6. PubMed ID: 12904684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-β1 expression in kidney allograft protocol biopsies during cyclosporine A therapy.
    Ortiz F; Helanterä IT; Räisänen-Sokolowski A; Honkanen EO; Koskinen PK
    Int J Artif Organs; 2013 Jan; 36(1):56-62. PubMed ID: 23280075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
    Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
    Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide.
    Sihm I; Thygesen K; Krusell LR; Lederballe O
    Blood Press; 2000; 9(6):346-54. PubMed ID: 11212064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safe introduction of angiotensin-converting enzyme inhibitor in renal allograft recipients.
    Wagner L; Fekete A; Rudolf A; Doros A; Langer RM
    Transplant Proc; 2012 Sep; 44(7):2151-3. PubMed ID: 22974939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
    Xu H; Tao LJ; Sun M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):61-4. PubMed ID: 16137008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy.
    Campistol JM; Iñigo P; Larios S; Bescos M; Oppenheimer F
    Nephrol Dial Transplant; 2001; 16 Suppl 1():114-6. PubMed ID: 11369837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of losartan on slowing progression of chronic allograft nephropathy.
    Wang PX; Fan MQ; Huang CB; Feng JY; Xiao Y; Fang ZQ; Zhang YP
    Chin Med Sci J; 2005 Dec; 20(4):231-6. PubMed ID: 16422249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats.
    Nagai M; Horikoshi K; Izumi T; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
    Cardiovasc Drugs Ther; 2004 Sep; 18(5):353-62. PubMed ID: 15717137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vascular impact of anti-hypertensive treatment and renal protection].
    Mogensen CE
    Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
    Wuerzner G; Chioléro A; Maillard M; Nussberger J; Brunner HR; Burnier M
    Kidney Int; 2004 Jan; 65(1):238-44. PubMed ID: 14675055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
    Noda M; Matsuo T; Fukuda R; Ohta M; Nagano H; Shibouta Y; Naka T; Nishikawa K; Imura Y
    Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
    Granger CB; McMurray JJ; Yusuf S; Held P; Michelson EL; Olofsson B; Ostergren J; Pfeffer MA; Swedberg K;
    Lancet; 2003 Sep; 362(9386):772-6. PubMed ID: 13678870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM; Santoni JP; Thomas JR; Van de Voorde K; Ketelslegers JM; Lambert AE
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.